| Literature DB >> 35597684 |
Mattia Lunardi1, Yves Louvard2, Thierry Lefèvre2, Goran Stankovic3, Francesco Burzotta4, Ghassan S Kassab5, Jens F Lassen6, Olivier Darremont7, Scot Garg8, Bon-Kwon Koo9, Niels R Holm10, Thomas W Johnson11, Manuel Pan12, Yiannis S Chatzizisis13, Adrian Banning14, Alaide Chieffo15, Dariusz Dudek16, David Hildick-Smith17, Jérome Garot2, Timothy D Henry18, George Dangas19, Gregg W Stone19, Mitchell W Krucoff20, Donald Cutlip21, Roxana Mehran19, William Wijns22, Faisal Sharif23, Patrick W Serruys24, Yoshinobu Onuma23.
Abstract
The Bifurcation Academic Research Consortium (Bif-ARC) project originated from the need to overcome the paucity of standardization and comparability between studies involving bifurcation coronary lesions. This document is the result of a collaborative effort between academic research organizations and the most renowned interventional cardiology societies focused on bifurcation lesions in Europe, the United States, and Asia. This consensus provides standardized definitions for bifurcation lesions; the criteria to judge the side branch relevance; the procedural, mechanistic, and clinical endpoints for every type of bifurcation study; and the follow-up methods. Considering the complexity of bifurcation lesions and their evaluation, detailed instructions and technical aspects for site and core laboratory analysis of bifurcation lesions are also reported. The recommendations included within this consensus will facilitate pooled analyses and the effective comparison of data in the future, improving the clinical relevance of trials in bifurcation lesions, and the quality of care in this subset of patients.Entities:
Keywords: Academic Research Consortium; bifurcation; clinical trials; endpoints
Mesh:
Year: 2022 PMID: 35597684 DOI: 10.1016/j.jacc.2022.04.024
Source DB: PubMed Journal: J Am Coll Cardiol ISSN: 0735-1097 Impact factor: 27.203